Tatva Chintan

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE0GK401011
  • NSEID: TATVA
  • BSEID: 543321
INR
1,360.75
47.35 (3.61%)
BSENSE

May 07

BSE+NSE Vol: 62.6 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003512,
    "name": "Tatva Chintan",
    "stock_name": "Tatva Chintan",
    "full_name": "Tatva Chintan Pharma Chem Ltd",
    "name_url": "stocks-analysis/tatva-chintan",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,360.75",
    "chg": 47.35,
    "chgp": "3.61%",
    "dir": 1,
    "prev_price": "1,313.40",
    "mcapval": "3,102.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543321,
    "symbol": "TATVA",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE0GK401011",
    "curr_date": "May 07",
    "curr_time": "",
    "bse_nse_vol": "62.6 k",
    "exc_status": "Active",
    "traded_date": "May 07, 2026",
    "traded_date_str": "2026 05 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tatva-chintan-1003512-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Tatva Chintan Pharma Chem Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-tatva-chintan-pharma-chem-ltd-3980477",
        "imagepath": "",
        "date": "2026-05-07 23:17:14",
        "description": "The next results date for Tatva Chintan Pharma Chem Ltd is scheduled for 16 May 2026...."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3976995",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TatvaChintanPha_technicaldot_3976995.png",
        "date": "2026-05-06 08:06:18",
        "description": "Tatva Chintan Pharma Chem Ltd, a small-cap player in the specialty chemicals sector, has recently exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite mixed signals from key technical indicators, the stock’s price action and momentum metrics suggest a cautiously optimistic outlook for investors navigating the current market environment."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-technical-momentum-shifts-amid-mixed-signals-3975002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TatvaChintanPha_technicaldot_3975002.png",
        "date": "2026-05-05 08:07:40",
        "description": "Tatva Chintan Pharma Chem Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a modest day decline of 0.26%, the stock’s mixed technical indicators and recent rating downgrade from Buy to Hold by MarketsMOJO highlight a nuanced outlook for investors navigating this evolving landscape."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-hold-3971995",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TatvaChintanPha_mojoScore_3971995.png",
        "date": "2026-05-01 10:10:42",
        "description": "Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-technical-momentum-shifts-amid-mixed-market-signals-3969515",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/TatvaChintanPha_technicaldot_3969515.png",
        "date": "2026-04-30 08:03:28",
        "description": "Tatva Chintan Pharma Chem Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s mixed technical indicators suggest a nuanced outlook for investors navigating the current market environment."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3965717",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/TatvaChintanPha_technicaldot_3965717.png",
        "date": "2026-04-28 08:06:08",
        "description": "Tatva Chintan Pharma Chem Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a 4.32% gain on 28 Apr 2026, the stock’s technical landscape presents a nuanced picture for investors navigating the specialty chemicals sector."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-hold-3953929",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/TatvaChintanPha_mojoScore_3953929.png",
        "date": "2026-04-20 10:10:03",
        "description": "Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-hold-by-marketsmojo-3939540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/TatvaChintanPha_mojoScore_3939540.png",
        "date": "2026-04-09 10:10:03",
        "description": "Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Opens 5.57% Lower as Technicals Signal Continued Downside",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-opens-with-weak-start-significant-gap-down-amid-market-concerns-3933906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/TatvaChintanPha_gapdown_3933906.png",
        "date": "2026-04-06 09:35:19",
        "description": ""
      }
    ],
    "total": 478,
    "sid": "1003512",
    "stock_news_url": "https://www.marketsmojo.com/news/tatva-chintan-pharma-chem-1003512"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-May-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter and financial year ended 31 March 2026 is scheduled on Saturday 16 May 2026 at 05:00 p.m. IST. The Call is hosted by ICICI Securities and an invite in this regard is attached for your information and records",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday 16.05.2026",
      "datetime": "06-May-2026",
      "details": "Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 inter alia to consider and approve 1. consider and approve and take on record the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31 March 2026; 2. consider and recommend a final dividend if any on the equity shares of the Company for the financial year ended 31 March 2026 subject to approval of the shareholders at the ensuing Annual General Meeting of the Company. Further in accordance with the Companys Code of Conduct for Prohibition of Insider Trading the Company has intimated its designated persons regarding the closure of the Trading Window for trading in the Companys equity shares from 01 April 2026 till the expiry of 48 hours from the date the said financial results are made public.",
      "source": "BSE"
    },
    {
      "caption": "Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2",
      "datetime": "29-Apr-2026",
      "details": "<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Tatva Chintan Pharma Chem Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24232GJ1996PLC029894</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>FY 2025-26 and FY 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>FY 2024-25 and FY 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Ishwar Nayi</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Ajesh Pillai</td></tr> <tr><td>Designation : -</td><td>Chief Financial Officer</td></tr></table><div> <br/> Date: 29/04/2026<br/><br/></div>",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "16 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Tatva Chintan Pharma Chem Ltd has declared <strong>10%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

06-May-2026 | Source : BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter and financial year ended 31 March 2026 is scheduled on Saturday 16 May 2026 at 05:00 p.m. IST. The Call is hosted by ICICI Securities and an invite in this regard is attached for your information and records

Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday 16.05.2026

06-May-2026 | Source : BSE

Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 inter alia to consider and approve 1. consider and approve and take on record the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31 March 2026; 2. consider and recommend a final dividend if any on the equity shares of the Company for the financial year ended 31 March 2026 subject to approval of the shareholders at the ensuing Annual General Meeting of the Company. Further in accordance with the Companys Code of Conduct for Prohibition of Insider Trading the Company has intimated its designated persons regarding the closure of the Trading Window for trading in the Companys equity shares from 01 April 2026 till the expiry of 48 hours from the date the said financial results are made public.

Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

29-Apr-2026 | Source : BSE

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Tatva Chintan Pharma Chem Ltd
2 CIN NO. L24232GJ1996PLC029894
3 Report filed for FY 2025-2026
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* FY 2025-26 and FY 2026-27
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)FY 2024-25 and FY 2025-26
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-Ishwar Nayi
Designation :-Company Secretary and Compliance Officer
Name of the Chief Financial Officer :- Ajesh Pillai
Designation : -Chief Financial Officer

Date: 29/04/2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

16 May 2026

stock-summary
DIVIDEND

Tatva Chintan Pharma Chem Ltd has declared 10% dividend, ex-date: 12 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available